INS and type 2 diabetes mellitus: The recent SITA-HOSPITAL randomized controlled study investigated 279 noncritical care patients with type 2 diabetes and showed that oral sitagliptin plus basal insulin led to similar glycemic control than the more labor-intensive basal–bolus insulin regimen [56].